Learn more in our case study on how we used our advanced HRMS capabilities, detailed analytical outputs, and close, transparent communication to quickly identify high-risk proteins and advise process changes to de-risk a client’s biotherapeutic. Read the Case Study Now:
Type: Case Study
A highly efficient method of plasma fractionation that has the potential to address the growing global IG product shortage. Read the Case Study Now:
When doing Host Cell Protein analysis by mass spectrometry, we often fail to appreciate the “why” of the HCPs that show up in our protein lists – why did these HCPs co-purify with the Product, and why are they important? Clusterin shows up in almost every HCP project we work on. Why?